Tangible Shareholders Equity: The value shareholders equity less intangible assets.
Insight Molecular Diagnostics Inc. (IMDX) had Tangible Shareholders Equity of $-23.80M for the most recently reported fiscal quarter, ending 2025-09-30.
| Income Statement Financials | |
$0.26M |
|
$-10.85M |
|
$0.12M |
|
$0.14M |
|
$11.31M |
|
$-11.05M |
|
$0.19M |
|
$-10.85M |
|
$-10.85M |
|
$-10.85M |
|
$-10.85M |
|
$-10.85M |
|
$-10.85M |
|
$-11.05M |
|
$-10.46M |
|
32.03M |
|
32.03M |
|
$-0.34 |
|
$-0.34 |
|
| Balance Sheet Financials | |
$21.39M |
|
$4.15M |
|
$22.55M |
|
$43.94M |
|
$7.66M |
|
-- |
|
$45.47M |
|
$53.13M |
|
$-9.20M |
|
|
Tangible Shareholders Equity |
$-23.80M |
$-9.20M |
|
28.62M |
|
| Cash Flow Statement Financials | |
$-16.64M |
|
$-1.71M |
|
$28.32M |
|
$10.34M |
|
$20.21M |
|
$9.87M |
|
$1.50M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
2.79 |
|
-- |
|
-- |
|
-- |
|
-- |
|
53.46% |
|
-4249.23% |
|
-4249.23% |
|
-- |
|
-4174.61% |
|
-4174.61% |
|
$-18.34M |
|
-- |
|
-- |
|
-- |
|
0.01 |
|
0.26 |
|
1.01 |
|
89.31 |
|
118.03% |
|
45.61% |
|
-24.70% |
|
118.03% |
|
$-0.32 |
|
$-0.57 |
|
$-0.52 |
|